Search
GeneDx Holdings Corp
WGSAdd to Watchlist
59.010USD
+2.590+4.59%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.75BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of GeneDx Holdings Corp is 8.67, ranking 8 out of 76 in the Healthcare Providers & Services industry. The average price target is 160.00, with a high of 185.00 and a low of 140.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
88.111
Target Price
+49.32%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
GeneDx Holdings Corp
WGS
9
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is GeneDx Holdings Corp's expected revenue for the next quarter?
GeneDx Holdings Corp's expected revenue is 111.01M.
What is GeneDx Holdings Corp's price target?
Analysts forecast that GeneDx Holdings Corp's price target is USD 160.00, with the highest forecast at USD 185.00 and the lowest forecast at USD 140.00.
How have GeneDx Holdings CorpWGS's recent earnings per share performed?
The market expectation was USD -2.16, while GeneDx Holdings CorpWGS's earnings per share (EPS) for the previous quarter was USD -0.61. EPS for the next quarter is expected at USD -0.19.
What is the analyst rating for GeneDx Holdings Corp?
Based on the ratings of GeneDx Holdings Corp's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
